Advisors Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Advisors Asset Management's ADMA Position: Q3 2026 in Review
Advisors Asset Management reduced its ADMA Biologics (ADMA) stake by 18% in Q3 2026, selling an estimated $11.8K and leaving 5,972 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.
Advisors Asset Management first reported a position in ADMA in Q2 2025 and has held it in 6 quarters since. The position peaked at $87.4K in Q4 2025. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Advisors Asset Management held 5,972 shares of ADMA Biologics worth $59.9K as of Q3 2026.
- Advisors Asset Management sold 1,278 ADMA Biologics shares in Q3 2026, an estimated $11.8K.
- ADMA Biologics made up ﹤0.01% of Advisors Asset Management's portfolio in Q3 2026, its #1314 holding.
- Advisors Asset Management first reported a position in ADMA Biologics in Q2 2025 and has held it in 6 quarters since.
- Advisors Asset Management's ADMA Biologics position peaked at $87.4K in Q4 2025.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Advisors Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.